SCID and Other Inborn Errors of Immunity with Low TRECs - the Brazilian Experience

Lucila Akune Barreiros1, Jusley Lira Sousa1, Christoph Geier2

  • 1Laboratory of Human Immunology, Department of Immunology, Institute of Biomedical Sciences, University of São Paulo, 1730, Av. Professor Lineu Prestes, Sao Paulo, SP, 05508-000, Brazil.

Insights

Severe combined immunodeficiency (SCID) is a critical pediatric emergency. Early diagnosis and treatment are vital, as delays significantly reduce survival rates and treatment success in Brazilian patients.

Area of Science:

  • Immunology
  • Pediatrics
  • Genetics

Background:

  • Severe combined immunodeficiency (SCID) is a life-threatening pediatric emergency caused by absent or non-functional T cells.
  • Infants with SCID often appear healthy at birth, necessitating newborn screening (NBS) for early detection before severe infections occur.
  • Delayed diagnosis and treatment in Brazil lead to poor outcomes, highlighting the need for improved screening and medical education.

Purpose of the Study:

  • To report on 47 Brazilian patients investigated for SCID between 2009 and 2020.
  • To analyze diagnostic delays, treatment outcomes, and survival rates in SCID patients in Brazil.
  • To assess the impact of improved medical education and advocate for universal NBS-SCID implementation.

Main Methods:

  • Retrospective analysis of 47 Brazilian patients with suspected SCID based on clinical presentation, family history, or low TRECs.
  • Clinical and laboratory findings, genetic testing, and treatment outcomes were reviewed.
  • Survival rates and the success of hematopoietic stem-cell transplantation were evaluated.

Main Results:

  • 24 typical SCID, 14 leaky SCID, and 6 Omenn syndrome cases were diagnosed among the 47 patients.
  • Median age at onset was 2 months, but diagnosis and treatment were delayed to 6.5 and 11.5 months, respectively.
  • Overall survival was 51.1%, with only 66.7% undergoing transplantation, which was successful in 70% of those cases. Genetic testing success rate was 65.1%.

Conclusions:

  • Significant diagnostic and treatment delays impact SCID patient survival in Brazil.
  • Improved medical education has aided SCID diagnosis, but an estimated 80% of cases remain missed.
  • Universal NBS-SCID implementation, starting in São Paulo, is crucial for early diagnosis and improved survival rates for SCID patients in Brazil.

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.2K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
467
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
74.5K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
280